Symbol:
Sftpa1
Name:
surfactant protein A1
RGD ID:
3665
Description:
Predicted to enable carbohydrate binding activity and metal ion binding activity. Involved in several processes, including cellular response to mechanical stimulus; cellular response to nitric oxide; and response to vitamin A. Located in extracellular space and multivesicular body. Biomarker of asthma; congenital diaphragmatic hernia; lung disease (multiple); and obesity. Human ortholog(s) of this gene implicated in lung disease (multiple) and respiratory syncytial virus infectious disease. Orthologous to human SFTPA1 (surfactant protein A1) and SFTPA2 (surfactant protein A2); PARTICIPATES IN forkhead class A signaling pathway; phagocytosis pathway; INTERACTS WITH (R)-lipoic acid; 1,2-dimethylhydrazine; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC100364823; LOC102557073; MGC105453; PSAP; PSP-A; pulmonary surfactant-associated protein A; pulmonary surfactant-associated protein A-like; Sftp1; Sftpa; Sftpl; SP-A; surfactant associated protein A; surfactant, pulmonary-associated protein A1; Surfactant-associated protein 1 (pulmonary surfactant protein SP-A); Surfactant-associated protein 1 (pulmonary surfactant protein, SP-A)
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 16 17,042,264 - 17,045,770 (+) NCBI GRCr8 GRCr8 GRCr8 GRCr8 Ensembl 16 17,042,255 - 17,045,769 (+) Ensembl GRCr8 mRatBN7.2 16 17,008,180 - 17,011,686 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 16 17,008,180 - 17,011,685 (+) Ensembl mRatBN7.2 UTH_Rnor_SHR_Utx 16 17,072,970 - 17,076,475 (+) NCBI UTH_Rnor_SHR_Utx UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 16 18,199,439 - 18,202,946 (+) NCBI UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 16 17,125,874 - 17,129,379 (+) NCBI UTH_Rnor_WKY_Bbb_1.0 UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 16 18,716,019 - 18,719,404 (+) NCBI Rnor_6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 16 18,716,019 - 18,719,403 (+) Ensembl rn6 Rnor6.0 Rnor_5.0 16 18,585,631 - 18,589,016 (+) NCBI Rnor_5.0 Rnor_5.0 rn5 RGSC_v3.4 16 17,570,887 - 17,574,389 (+) NCBI RGSC_v3.4 RGSC_v3.4 rn4 Celera 16 17,235,343 - 17,236,847 (+) NCBI Celera Cytogenetic Map 16 p14 NCBI
JBrowse:
Gene Location: 16:17042264..17045770
17.0425M 17.0430M 17.0435M 17.0440M 17.0445M 17.0450M 17.0455M NM_001270645 (Sftpa1) NM_001270647 (Sftpa1) NM_017329 (Sftpa1) XM_039094199 (Sftpa1)
Only show annotations with direct experimental evidence (0 objects hidden)
Sftpa1 Rat Acute Lung Injury ISO SFTPA1 (Homo sapiens) 4143451 mRNA, protein:increased expression:pneumocyte RGD Sftpa1 Rat adult respiratory distress syndrome ISO SFTPA1 (Homo sapiens) 4143436 protein:increased expression:serum RGD Sftpa1 Rat adult respiratory distress syndrome ISO SFTPA1 (Homo sapiens) 4143379 protein:decreased expression:lung RGD Sftpa1 Rat asthma ISO Sftpa1 (Mus musculus) 4143289 RGD Sftpa1 Rat asthma ISO SFTPA1 (Homo sapiens) 4143462 protein:decreased expression:lung RGD Sftpa1 Rat asthma IEP 4143398 protein:decreased expression:lung, Clara cell, pneumocyte RGD Sftpa1 Rat asthma IEP 4143516 mRNA, protein:increased expression:lung RGD Sftpa1 Rat bacterial pneumonia IEP 4143464 protein:increased expression:lung RGD Sftpa1 Rat Bronchial Hyperreactivity ISO Sftpa1 (Mus musculus) 4143407 protein:decreased expression:lung RGD Sftpa1 Rat bronchopulmonary dysplasia ISO SFTPA1 (Homo sapiens) 4143384 DNA:snps, haplotypes:multiple (human) RGD Sftpa1 Rat bronchopulmonary dysplasia susceptibility ISO SFTPA1 (Homo sapiens) 4144876 DNA:polymorphisms, haplotype: (human) RGD Sftpa1 Rat chronic obstructive pulmonary disease susceptibility ISO SFTPA1 (Homo sapiens) 4143423 DNA:polymorphism:cds:c.186G>A (human) RGD Sftpa1 Rat chronic obstructive pulmonary disease ISO SFTPA1 (Homo sapiens) 4143288 protein:increased expression:lung RGD Sftpa1 Rat chronic obstructive pulmonary disease ISO SFTPA1 (Homo sapiens) 4143281 DNA:SNP:cds:p.L50V (human) RGD Sftpa1 Rat congenital diaphragmatic hernia treatment IEP 151667435 RGD Sftpa1 Rat Cough susceptibility ISO SFTPA1 (Homo sapiens) 4144873 DNA:SNPs, haplotypes:cds:multiple (human) RGD Sftpa1 Rat cystic fibrosis ISO SFTPA1 (Homo sapiens) 4143403 protein:decreased expression:lung RGD Sftpa1 Rat extrinsic allergic alveolitis ISO SFTPA1 (Homo sapiens) 4143437 protein:decreased expression:lung RGD Sftpa1 Rat Fungal Lung Diseases susceptibility ISO Sftpa1 (Mus musculus) 4143489 RGD Sftpa1 Rat Hydrops Fetalis ISO SFTPA1 (Homo sapiens) 4143453 protein:decreased expression:lung RGD Sftpa1 Rat Hyperoxia IEP 4143429 mRNA, protein:increased expression:lung RGD Sftpa1 Rat Hyperoxia IEP 4143387 mRNA:increased expression:bronchus, Clara cell RGD Sftpa1 Rat interstitial lung disease ISO SFTPA1 (Homo sapiens) 4143449 protein:increased expression:serum RGD Sftpa1 Rat interstitial lung disease ISO SFTPA1 (Homo sapiens) 4143430 protein:decreased expression:lung RGD Sftpa1 Rat lung disease ISO SFTPA1 (Homo sapiens) 4143448 associated with Cystic Fibrosis;protein:increased expression:lung RGD Sftpa1 Rat lung disease IEP 4143446 Meconium Aspiration Syndrome;protein:decreased expression:lung RGD Sftpa1 Rat lung disease ISO SFTPA1 (Homo sapiens) 4144871 associated with Cystic Fibrosis RGD Sftpa1 Rat lung disease IEP 4143505 Lung Injury RGD Sftpa1 Rat newborn respiratory distress syndrome susceptibility ISO SFTPA1 (Homo sapiens) 4143433 DNA:missense mutations, haplotype:cds:p.L50V, p.R219W (human) RGD Sftpa1 Rat newborn respiratory distress syndrome IEP 4143428 protein:increased expression:lung RGD Sftpa1 Rat obesity IEP 4143472 protein:increased expression:lung RGD Sftpa1 Rat pneumocystosis ISO Sftpa1 (Mus musculus) 4143431 protein:increased expression:lung RGD Sftpa1 Rat pneumonia ISO Sftpa1 (Mus musculus) 4143394 RGD Sftpa1 Rat pneumonia ISO SFTPA1 (Homo sapiens) 4143452 protein:decreased expression:lung RGD Sftpa1 Rat pulmonary alveolar proteinosis ISO Sftpa1 (Mus musculus) 4143454 protein:increased expression:lung RGD Sftpa1 Rat pulmonary alveolar proteinosis ISO SFTPA1 (Homo sapiens) 4143450 protein:altered polymerization:lung RGD Sftpa1 Rat pulmonary alveolar proteinosis severity ISO SFTPA1 (Homo sapiens) 4143411 protein:increased expression:blood RGD Sftpa1 Rat pulmonary edema susceptibility ISO SFTPA1 (Homo sapiens) 4144872 DNA:SNPs:cds:1101C>T, 3192T>C, 3234T>C (human) RGD Sftpa1 Rat pulmonary fibrosis ISO SFTPA1 (Homo sapiens) 4143437 protein:decreased expression:lung RGD Sftpa1 Rat pulmonary fibrosis susceptibility ISO SFTPA1 (Homo sapiens) 4143409 DNA:missense mutations, haplotype:cds:p.L50V, p.R219W (human) RGD Sftpa1 Rat pulmonary fibrosis disease_progression ISO SFTPA1 (Homo sapiens) 4144870 mRNA:increased expression:lung RGD Sftpa1 Rat pulmonary sarcoidosis ISO SFTPA1 (Homo sapiens) 4143437 protein:decreased expression:lung RGD Sftpa1 Rat pulmonary tuberculosis susceptibility ISO SFTPA1 (Homo sapiens) 4144875 DNA:SNP:intron:1416C>T (human) RGD Sftpa1 Rat pulmonary tuberculosis susceptibility ISO SFTPA1 (Homo sapiens) 4144874 DNA:SNPs:exons:307G>A, 776C>T (human) RGD Sftpa1 Rat respiratory syncytial virus infectious disease susceptibility ISO SFTPA1 (Homo sapiens) 4143495 DNA:polymorphisms, haplotype: (human) RGD Sftpa1 Rat respiratory syncytial virus infectious disease ISO SFTPA1 (Homo sapiens) 4143439 protein:decreased expression:lung RGD Sftpa1 Rat sinusitis ISO SFTPA1 (Homo sapiens) 4143506 associated with Cystic Fibrosis;mRNA:increased expression:respiratory system mucosa RGD
Only show annotations with direct experimental evidence (0 objects hidden)
Sftpa1 Rat (R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid affects the reaction [Paraquat affects the expression of SFTPA1 mRNA] CTD PMID:25215149 Sftpa1 Rat (S)-nicotine increases expression ISO Sftpa1 (Mus musculus) 6480464 Nicotine results in increased expression of SFTPA1 mRNA CTD PMID:9458815 Sftpa1 Rat (S)-nicotine multiple interactions ISO Sftpa1 (Mus musculus) 6480464 Tubocurarine inhibits the reaction [Nicotine results in increased expression of SFTPA1 mRNA] CTD PMID:9458815 Sftpa1 Rat 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of SFTPA1 mRNA CTD PMID:27840820 Sftpa1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Sftpa1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SFTPA1 mRNA CTD PMID:19372248 Sftpa1 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SFTPA1 mRNA CTD PMID:18990726 Sftpa1 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SFTPA1 mRNA CTD PMID:22504374 Sftpa1 Rat ambroxol multiple interactions EXP 6480464 Ambroxol inhibits the reaction [Paraquat results in decreased expression of SFTPA1 protein] CTD PMID:16824340 Sftpa1 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SFTPA1 mRNA CTD PMID:16483693 Sftpa1 Rat anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [Silicon Dioxide results in decreased expression of SFTPA1 protein] CTD PMID:35689653 Sftpa1 Rat ATP multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 [SFTPA1 protein polymorphism binds to SFTPA2 protein polymorphism] inhibits the reaction [Adenosine Triphosphate results in more ... CTD PMID:15065867 Sftpa1 Rat benzo[a]pyrene decreases expression ISO Sftpa1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SFTPA1 mRNA CTD PMID:22228805 Sftpa1 Rat benzo[a]pyrene affects methylation ISO SFTPA1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SFTPA1 promoter CTD PMID:27901495 Sftpa1 Rat benzo[a]pyrene increases methylation ISO SFTPA1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SFTPA1 3' UTR; Benzo(a)pyrene results in increased methylation of more ... CTD PMID:27901495 Sftpa1 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SFTPA1 gene CTD PMID:28505145 Sftpa1 Rat bisphenol F decreases expression ISO Sftpa1 (Mus musculus) 6480464 bisphenol F results in decreased expression of SFTPA1 mRNA CTD PMID:38685157 Sftpa1 Rat bleomycin A2 multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 [Bleomycin co-treated with SFTPA1 protein polymorphism] results in increased expression of CXCL8 protein; [Bleomycin co-treated more ... CTD PMID:14617519 Sftpa1 Rat bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of SFTPA1 protein CTD PMID:25933445 Sftpa1 Rat bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of SFTPA1 mRNA CTD PMID:15782499 Sftpa1 Rat bosentan multiple interactions EXP 6480464 Bosentan inhibits the reaction [Nitric Oxide Donors results in decreased expression of SFTPA1 mRNA]; Bosentan more ... CTD PMID:15640287 Sftpa1 Rat butanal decreases expression ISO SFTPA1 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of SFTPA1 mRNA CTD PMID:26079696 Sftpa1 Rat cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of SFTPA1 promoter CTD PMID:22457795 Sftpa1 Rat calcitriol decreases expression ISO SFTPA1 (Homo sapiens) 6480464 Calcitriol results in decreased expression of SFTPA1 mRNA; Calcitriol results in decreased expression of SFTPA1 more ... CTD PMID:15951333 Sftpa1 Rat carbon nanotube decreases expression ISO Sftpa1 (Mus musculus) 6480464 Nanotubes, Carbon results in decreased expression of SFTPA1 mRNA CTD PMID:25554681 Sftpa1 Rat CGP 52608 multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SFTPA1 gene] CTD PMID:28238834 Sftpa1 Rat decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of SFTPA1 mRNA CTD PMID:23640034 Sftpa1 Rat dexamethasone decreases expression ISO SFTPA1 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of SFTPA1 mRNA CTD PMID:16857225 Sftpa1 Rat dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of SFTPA1 mRNA CTD PMID:23354098 Sftpa1 Rat dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [nitrofen results in decreased expression of SFTPA1 mRNA]; Dexamethasone inhibits the more ... CTD PMID:11051153|PMID:23354098 Sftpa1 Rat dexamethasone multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 Thiram inhibits the reaction [Dexamethasone results in decreased expression of SFTPA1 mRNA] CTD PMID:16857225 Sftpa1 Rat dichloroacetic acid increases expression ISO Sftpa1 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of SFTPA1 mRNA CTD PMID:28962523 Sftpa1 Rat dihydrogen multiple interactions EXP 6480464 Hydrogen inhibits the reaction [nitrofen results in decreased expression of SFTPA1 mRNA] CTD PMID:34502408 Sftpa1 Rat dioxygen multiple interactions ISO Sftpa1 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SFTPA1 mRNA CTD PMID:30529165 Sftpa1 Rat diprotium multiple interactions EXP 6480464 Hydrogen inhibits the reaction [nitrofen results in decreased expression of SFTPA1 mRNA] CTD PMID:34502408 Sftpa1 Rat epoxiconazole affects expression ISO Sftpa1 (Mus musculus) 6480464 epoxiconazole affects the expression of SFTPA1 mRNA CTD PMID:35436446 Sftpa1 Rat fumonisin B1 increases expression ISO Sftpa1 (Mus musculus) 6480464 fumonisin B1 results in increased expression of SFTPA1 mRNA CTD PMID:27376354 Sftpa1 Rat furan increases methylation EXP 6480464 furan results in increased methylation of SFTPA1 gene CTD PMID:22079235 Sftpa1 Rat furan increases expression ISO Sftpa1 (Mus musculus) 6480464 furan results in increased expression of SFTPA1 mRNA CTD PMID:24183702 Sftpa1 Rat lipoic acid multiple interactions EXP 6480464 Thioctic Acid affects the reaction [Paraquat affects the expression of SFTPA1 mRNA] CTD PMID:25215149 Sftpa1 Rat lipopolysaccharide multiple interactions ISO Sftpa1 (Mus musculus) 6480464 ERBB4 protein affects the reaction [Lipopolysaccharides results in increased expression of SFTPA1 mRNA]; ERBB4 protein more ... CTD PMID:21724861 Sftpa1 Rat lipopolysaccharide increases expression ISO SFTPA1 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of SFTPA1 mRNA CTD PMID:23567252 Sftpa1 Rat lipopolysaccharide increases expression ISO Sftpa1 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of SFTPA1 mRNA CTD PMID:21724861 Sftpa1 Rat lipopolysaccharide decreases expression ISO Sftpa1 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of SFTPA1 protein CTD PMID:21724861 Sftpa1 Rat liraglutide increases expression EXP 6480464 Liraglutide results in increased expression of SFTPA1 mRNA CTD PMID:23354098 Sftpa1 Rat liraglutide multiple interactions EXP 6480464 Liraglutide inhibits the reaction [nitrofen results in decreased expression of SFTPA1 mRNA]; Liraglutide inhibits the more ... CTD PMID:23354098 Sftpa1 Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of SFTPA1 mRNA CTD PMID:22504374 Sftpa1 Rat N-acetyl-L-cysteine multiple interactions ISO Sftpa1 (Mus musculus) 6480464 Acetylcysteine affects the reaction [Particulate Matter affects the expression of SFTPA1 protein] CTD PMID:31449845 Sftpa1 Rat N-acetyl-L-cysteine multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Silicon Dioxide results in decreased expression of SFTPA1 protein] CTD PMID:35689653 Sftpa1 Rat nickel atom decreases expression ISO Sftpa1 (Mus musculus) 6480464 Nickel results in decreased expression of SFTPA1 mRNA CTD PMID:12540486 Sftpa1 Rat nickel sulfate decreases expression ISO Sftpa1 (Mus musculus) 6480464 nickel sulfate results in decreased expression of SFTPA1 mRNA CTD PMID:11893692 Sftpa1 Rat nicotine increases expression ISO Sftpa1 (Mus musculus) 6480464 Nicotine results in increased expression of SFTPA1 mRNA CTD PMID:9458815 Sftpa1 Rat nicotine multiple interactions ISO Sftpa1 (Mus musculus) 6480464 Tubocurarine inhibits the reaction [Nicotine results in increased expression of SFTPA1 mRNA] CTD PMID:9458815 Sftpa1 Rat nitric oxide multiple interactions EXP 6480464 bosentan inhibits the reaction [Nitric Oxide results in decreased expression of SFTPA1 mRNA]; PD 156707 more ... CTD PMID:15640287 Sftpa1 Rat nitric oxide decreases expression EXP 6480464 Nitric Oxide results in decreased expression of SFTPA1 mRNA CTD PMID:15640287 Sftpa1 Rat nitrofen multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [nitrofen results in decreased expression of SFTPA1 mRNA]; Dexamethasone inhibits the more ... CTD PMID:11051153|PMID:23354098|PMID:34502408 Sftpa1 Rat nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of SFTPA1 mRNA; nitrofen results in decreased expression of SFTPA1 more ... CTD PMID:11051153|PMID:11057544|PMID:23354098|PMID:34502408 Sftpa1 Rat ozone multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 Ozone inhibits the reaction [[SFTPA1 protein polymorphism binds to SFTPA2 protein polymorphism] inhibits the reaction more ... CTD PMID:11781168|PMID:14617519|PMID:15065867|PMID:37386634 Sftpa1 Rat ozone decreases expression EXP 6480464 Ozone results in decreased expression of SFTPA1 mRNA CTD PMID:28549673 Sftpa1 Rat ozone multiple interactions ISO Sftpa1 (Mus musculus) 6480464 Ozone results in increased oxidation of [SFTPA1 protein binds to SFTPA1 protein]; SFTPA1 gene mutant more ... CTD PMID:17307210 Sftpa1 Rat ozone increases oxidation ISO Sftpa1 (Mus musculus) 6480464 Ozone results in increased oxidation of SFTPA1 protein CTD PMID:17307210 Sftpa1 Rat ozone increases expression ISO Sftpa1 (Mus musculus) 6480464 Ozone results in increased expression of SFTPA1 mRNA CTD PMID:17307210 Sftpa1 Rat ozone affects response to substance ISO SFTPA1 (Homo sapiens) 6480464 SFTPA1 protein affects the susceptibility to Ozone CTD PMID:11781168 Sftpa1 Rat ozone increases oxidation ISO SFTPA1 (Homo sapiens) 6480464 Ozone results in increased oxidation of SFTPA1 protein polymorphism CTD PMID:14617519|PMID:15065867 Sftpa1 Rat paraquat increases expression ISO SFTPA1 (Homo sapiens) 6480464 Paraquat results in increased expression of SFTPA1 protein CTD PMID:17174135 Sftpa1 Rat paraquat affects expression EXP 6480464 Paraquat affects the expression of SFTPA1 mRNA CTD PMID:25215149 Sftpa1 Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of SFTPA1 protein CTD PMID:17616020 Sftpa1 Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SFTPA1 mRNA; Paraquat results in decreased expression of SFTPA1 more ... CTD PMID:16824340|PMID:32680482 Sftpa1 Rat paraquat multiple interactions EXP 6480464 Ambroxol inhibits the reaction [Paraquat results in decreased expression of SFTPA1 protein]; Thioctic Acid affects more ... CTD PMID:16824340|PMID:25215149 Sftpa1 Rat phosphatidylcholine multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 [SFTPA1 protein polymorphism binds to SFTPA2 protein polymorphism] inhibits the reaction [Adenosine Triphosphate results in more ... CTD PMID:15065867 Sftpa1 Rat pioglitazone multiple interactions ISO Sftpa1 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SFTPA1 mRNA CTD PMID:27935865 Sftpa1 Rat reactive nitrogen species affects abundance ISO Sftpa1 (Mus musculus) 6480464 SFTPA1 protein affects the abundance of Reactive Nitrogen Species CTD PMID:15385504 Sftpa1 Rat resveratrol multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SFTPA1 mRNA CTD PMID:23557933 Sftpa1 Rat S-nitroso-N-acetyl-D-penicillamine decreases expression EXP 6480464 S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA CTD PMID:15640287 Sftpa1 Rat S-nitroso-N-acetyl-D-penicillamine multiple interactions EXP 6480464 bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA]; PD 156707 inhibits more ... CTD PMID:15640287 Sftpa1 Rat silicon carbide decreases expression EXP 6480464 silicon carbide results in decreased expression of SFTPA1 mRNA CTD PMID:14646272 Sftpa1 Rat silicon dioxide increases expression ISO SFTPA1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of SFTPA1 mRNA CTD PMID:25895662 Sftpa1 Rat silicon dioxide decreases expression ISO SFTPA1 (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of SFTPA1 protein CTD PMID:35689653 Sftpa1 Rat silicon dioxide multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Silicon Dioxide results in decreased expression of SFTPA1 protein]; JUN protein more ... CTD PMID:35689653 Sftpa1 Rat silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of SFTPA1 mRNA CTD PMID:18685790 Sftpa1 Rat thiram multiple interactions ISO SFTPA1 (Homo sapiens) 6480464 Thiram inhibits the reaction [Dexamethasone results in decreased expression of SFTPA1 mRNA] CTD PMID:16857225 Sftpa1 Rat titanium dioxide increases expression ISO Sftpa1 (Mus musculus) 6480464 titanium dioxide results in increased expression of SFTPA1 mRNA CTD PMID:23557971 Sftpa1 Rat troglitazone multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] which results in more ... CTD PMID:21153920 Sftpa1 Rat tubocurarine multiple interactions ISO Sftpa1 (Mus musculus) 6480464 Tubocurarine inhibits the reaction [Nicotine results in increased expression of SFTPA1 mRNA] CTD PMID:9458815 Sftpa1 Rat valproic acid increases methylation ISO SFTPA1 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of SFTPA1 gene CTD PMID:29154799 Sftpa1 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SFTPA1 mRNA CTD PMID:19015723 Sftpa1 Rat vitamin D decreases expression ISO Sftpa1 (Mus musculus) 6480464 Vitamin D deficiency results in decreased expression of SFTPA1 mRNA CTD PMID:32330513
Imported Annotations - KEGG (archival)
Imported Annotations - PID (archival)
(R)-lipoic acid (EXP) (S)-nicotine (ISO) 1,2-dimethylhydrazine (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 6-propyl-2-thiouracil (EXP) ambroxol (EXP) ammonium chloride (EXP) anthra[1,9-cd]pyrazol-6(2H)-one (ISO) ATP (ISO) benzo[a]pyrene (ISO) bisphenol A (EXP) bisphenol F (ISO) bleomycin A2 (EXP,ISO) bosentan (EXP) butanal (ISO) cadmium dichloride (EXP) calcitriol (ISO) carbon nanotube (ISO) CGP 52608 (ISO) decabromodiphenyl ether (EXP) dexamethasone (EXP,ISO) dichloroacetic acid (ISO) dihydrogen (EXP) dioxygen (ISO) diprotium (EXP) epoxiconazole (ISO) fumonisin B1 (ISO) furan (EXP,ISO) lipoic acid (EXP) lipopolysaccharide (ISO) liraglutide (EXP) methimazole (EXP) N-acetyl-L-cysteine (ISO) nickel atom (ISO) nickel sulfate (ISO) nicotine (ISO) nitric oxide (EXP) nitrofen (EXP) ozone (EXP,ISO) paraquat (EXP,ISO) phosphatidylcholine (ISO) pioglitazone (ISO) reactive nitrogen species (ISO) resveratrol (ISO) S-nitroso-N-acetyl-D-penicillamine (EXP) silicon carbide (EXP) silicon dioxide (EXP,ISO) thiram (ISO) titanium dioxide (ISO) troglitazone (EXP) tubocurarine (ISO) valproic acid (ISO) vinclozolin (EXP) vitamin D (ISO)
1.
Surfactant protein deficiency in familial interstitial lung disease.
Amin RS, etal., J Pediatr. 2001 Jul;139(1):85-92.
2.
Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN, etal., J Lab Clin Med. 2001 Jun;137(6):429-39.
3.
Attenuated allergic airway hyperresponsiveness in C57BL/6 mice is associated with enhanced surfactant protein (SP)-D production following allergic sensitization.
Atochina EN, etal., Respir Res. 2003 Dec 8;4:15. Print 2003.
4.
Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages.
Beharka AA, etal., J Immunol 2002 Oct 1;169(7):3565-73.
5.
Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).
Boon K, etal., PLoS One. 2009;4(4):e5134. Epub 2009 Apr 6.
6.
[Effect of intrauterine acute ischemic-hypoxia on the expression of lung SP-A and SP-B in neonatal rats]
Cai XX, etal., Zhonghua Er Ke Za Zhi. 2003 Mar;41(3):208-11.
7.
Mild vitamin A deficiency delays fetal lung maturation in the rat.
Chailley-Heu B, etal., Am J Respir Cell Mol Biol. 1999 Jul;21(1):89-96.
8.
Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
Choi EH, etal., Pediatr Pulmonol. 2006 Mar;41(3):255-62.
9.
Exudative lung injury is associated with decreased levels of surfactant proteins in a rat model of meconium aspiration.
Cleary GM, etal., Pediatrics. 1997 Dec;100(6):998-1003.
10.
Surfactant protein levels in bronchoalveolar lavage after segmental allergen challenge in patients with asthma.
Erpenbeck VJ, etal., Allergy. 2006 May;61(5):598-604.
11.
Rat pulmonary surfactant protein A is expressed as two differently sized mRNA species which arise from differential polyadenylation of one transcript.
Fisher JH, etal., Biochim Biophys Acta 1988 Sep 7;950(3):338-45.
12.
Serum surfactant protein D is increased in acute and chronic inflammation in mice.
Fujita M, etal., Cytokine. 2005 Jul 7;31(1):25-33.
13.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
14.
Relationship between pulmonary surfactant protein and lipid peroxidation in lung injury due to paraquat intoxication in rats.
Gil HW, etal., Korean J Intern Med. 2007 Jun;22(2):67-72.
15.
Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.
Greene KE, etal., Am J Respir Crit Care Med. 1999 Dec;160(6):1843-50.
16.
Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.
Griese M, etal., Am J Respir Crit Care Med. 2004 Nov 1;170(9):1000-5. Epub 2004 Jul 21.
17.
Antenatal dexamethasone enhances surfactant protein synthesis in the hypoplastic lung of nitrofen-induced diaphragmatic hernia in rats.
Guarino N, etal., J Pediatr Surg. 2000 Oct;35(10):1468-73. doi: 10.1053/jpsu.2000.16416.
18.
Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
Gunther A, etal., Am J Respir Crit Care Med. 1996 Jan;153(1):176-84.
19.
Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
Gunther A, etal., Eur Respir J. 1999 Sep;14(3):565-73.
20.
Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population.
Guo X, etal., Eur Respir J. 2001 Sep;18(3):482-90.
21.
Continuous mechanical contraction modulates expression of alveolar epithelial cell phenotype.
Gutierrez JA, etal., Am J Respir Cell Mol Biol. 2003 Jul;29(1):81-7. Epub 2003 Jan 31.
22.
Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome.
Haataja R, etal., Hum Mol Genet. 2000 Nov 1;9(18):2751-60.
23.
Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids.
Hattori A, etal., Am J Respir Cell Mol Biol. 1996 Jun;14(6):608-19.
24.
Nihon Kyobu Shikkan Gakkai zasshi
Honda Y Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Dec;34 Suppl:181-5.
25.
Surfactant composition in infants and young children with cystic fibrosis.
Hull J, etal., Am J Respir Crit Care Med. 1997 Jul;156(1):161-5.
26.
Effects of intrauterine IL-6 and IL-8 on the expression of surfactant apoprotein mRNAs in the fetal rat lung.
Ikegami T, etal., Eur J Obstet Gynecol Reprod Biol. 2000 Nov;93(1):97-103.
27.
Diminished lung compliance and elevated surfactant lipids and proteins in nutritionally obese young rats.
Inselman LS, etal., Lung. 2004;182(2):101-17.
28.
Pulmonary alveolar proteinosis in SCID mice.
Jennings VM, etal., Am J Respir Cell Mol Biol. 1995 Sep;13(3):297-306.
29.
Surfactant protein levels in severe respiratory syncytial virus infection.
Kerr MH and Paton JY, Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1115-8.
30.
Circadian rhythm of surfactant protein A, B and C mRNA in rats.
Kim CM, etal., Korean J Intern Med. 2003 Jun;18(2):76-82.
31.
Pulmonary collectins enhance phagocytosis of Mycobacterium avium through increased activity of mannose receptor.
Kudo K, etal., J Immunol. 2004 Jun 15;172(12):7592-602.
32.
Nitric oxide decreases surfactant protein gene expression in primary cultures of type II pneumocytes.
Lee JW, etal., Am J Physiol Lung Cell Mol Physiol. 2005 May;288(5):L950-7. Epub 2005 Jan 7.
33.
Effect of epidermal growth factor and dexamethasone on fetal rat lung development.
Ma L, etal., Chin Med J (Engl). 2009 Sep 5;122(17):2013-6.
34.
Association of polymorphisms in the collagen region of human SP-A1 and SP-A2 genes with pulmonary tuberculosis in Indian population.
Madan T, etal., Clin Chem Lab Med. 2002 Oct;40(10):1002-8.
35.
Susceptibility of mice genetically deficient in SP-A or SP-D gene to invasive pulmonary aspergillosis.
Madan T, etal., Mol Immunol. 2010 Jun;47(10):1923-30. Epub 2010 Apr 21.
36.
Variants of the SFTPA1 and SFTPA2 genes and susceptibility to tuberculosis in Ethiopia.
Malik S, etal., Hum Genet. 2006 Feb;118(6):752-9. Epub 2005 Nov 15.
37.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
38.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
39.
Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
Ohlmeier S, etal., J Proteome Res. 2008 Oct 30.
40.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
41.
Antagonistic effects of dexamethasone and retinoic acid on rat lung morphogenesis.
Oshika E, etal., Pediatr Res. 1998 Mar;43(3):315-24.
42.
Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia.
Pavlovic J, etal., Dis Markers. 2006;22(5-6):277-91.
43.
Respiratory symptoms among infants at risk for asthma: association with surfactant protein A haplotypes.
Pettigrew MM, etal., BMC Med Genet. 2007 Apr 2;8:15.
44.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
45.
PID Annotation Import Pipeline
Pipeline to import Pathway Interaction Database annotations from NCI into RGD
46.
Differential effects in vivo of thyroid hormone on the expression of surfactant phospholipid, surfactant protein mRNA and antioxidant enzyme mRNA in fetal rat lung.
Ramadurai SM, etal., Exp Lung Res. 1998 Sep-Oct;24(5):641-57.
47.
GOA pipeline
RGD automated data pipeline
48.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
49.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
50.
Total extracellular surfactant is increased but abnormal in a rat model of gram-negative bacterial pneumonia.
Russo TA, etal., Am J Physiol Lung Cell Mol Physiol. 2002 Sep;283(3):L655-63.
51.
Respiratory distress after intratracheal bleomycin: selective deficiency of surfactant proteins B and C.
Savani RC, etal., Am J Physiol Lung Cell Mol Physiol. 2001 Sep;281(3):L685-96.
52.
Association of polymorphisms in pulmonary surfactant protein A1 and A2 genes with high-altitude pulmonary edema.
Saxena S, etal., Chest. 2005 Sep;128(3):1611-9.
53.
Effects of maternal dexamethasone on expression of SP-A, SP-B, and SP-C in the fetal rat lung.
Schellhase DE and Shannon JM, Am J Respir Cell Mol Biol. 1991 Apr;4(4):304-12.
54.
Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration.
Schmidt R, etal., Respir Res. 2007 Jul 27;8:55.
55.
Decrease of the surface fraction of surfactant proteins containing clara cells and type II pneumocytes in a rat asthma model.
Schmiedl A, etal., Exp Toxicol Pathol. 2005 Mar;56(4-5):265-72.
56.
Distribution of surfactant proteins in type II pneumocytes of newborn, 14-day old, and adult rats: an immunoelectron microscopic and stereological study.
Schmiedl A, etal., Histochem Cell Biol. 2005 Dec;124(6):465-76. Epub 2005 Sep 27.
57.
Increased surfactant protein a and d expression in acute ovalbumin-induced allergic airway inflammation in brown norway rats.
Schmiedl A, etal., Int Arch Allergy Immunol. 2009;148(2):118-26. Epub 2008 Sep 19.
58.
Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis.
Selman M, etal., Hum Genet. 2003 Nov;113(6):542-50. Epub 2003 Sep 6.
59.
Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis.
Seymour JF, etal., Thorax. 2003 Mar;58(3):252-7.
60.
Sequence of rat surfactant protein A gene and functional mapping of its upstream region.
Smith CI, etal., Am J Physiol 1995 Nov;269(5 Pt 1):L603-12.
61.
Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.
Stamme C, etal., Am J Respir Cell Mol Biol 2002 Sep;27(3):353-60.
62.
Overexpression of surfactant protein SP-A, SP-B, and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury.
Sugahara K, etal., Lab Invest. 1996 Jan;74(1):209-20.
63.
Spatial and temporal expression of surfactant proteins in hyperoxia-induced neonatal rat lung injury.
ter Horst SA, etal., BMC Pulm Med. 2006 Apr 18;6:8.
64.
Transmission of surfactant protein variants and haplotypes in children hospitalized with respiratory syncytial virus.
Thomas NJ, etal., Pediatr Res. 2009 Jul;66(1):70-3.
65.
Immunohistochemical distribution of surfactant apoproteins in hypoplastic lungs of nonimmunologic hydrops fetalis.
Toki N, etal., Hum Pathol. 1995 Nov;26(11):1252-9.
66.
Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate.
van Diemen CC, etal., Eur Respir J. 2010 Apr;35(4):768-75. Epub 2009 Sep 24.
67.
Engineering novel complement activity into a pulmonary surfactant protein.
Venkatraman Girija U, etal., J Biol Chem. 2010 Apr 2;285(14):10546-52. doi: 10.1074/jbc.M109.097493. Epub 2010 Jan 29.
68.
Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants.
Weber B, etal., Turk J Pediatr. 2000 Jul-Sep;42(3):181-5.
69.
Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia.
White CW, etal., Am J Respir Cell Mol Biol. 2001 Jul;25(1):51-9.
70.
Sinonasal surfactant protein A1, A2, and D gene expression in cystic fibrosis: a preliminary report.
Woodworth BA, etal., Otolaryngol Head Neck Surg. 2007 Jul;137(1):34-8.
71.
Effect of inhaled budesonide on surfactant protein expression in asthmatic mice.
Yu ZW and Zhang JH, Allergy Asthma Proc. 2008 Sep-Oct;29(5):486-92.
Sftpa1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 16 17,042,264 - 17,045,770 (+) NCBI GRCr8 GRCr8 GRCr8 GRCr8 Ensembl 16 17,042,255 - 17,045,769 (+) Ensembl GRCr8 mRatBN7.2 16 17,008,180 - 17,011,686 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 16 17,008,180 - 17,011,685 (+) Ensembl mRatBN7.2 UTH_Rnor_SHR_Utx 16 17,072,970 - 17,076,475 (+) NCBI UTH_Rnor_SHR_Utx UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 16 18,199,439 - 18,202,946 (+) NCBI UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 16 17,125,874 - 17,129,379 (+) NCBI UTH_Rnor_WKY_Bbb_1.0 UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 16 18,716,019 - 18,719,404 (+) NCBI Rnor_6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 16 18,716,019 - 18,719,403 (+) Ensembl rn6 Rnor6.0 Rnor_5.0 16 18,585,631 - 18,589,016 (+) NCBI Rnor_5.0 Rnor_5.0 rn5 RGSC_v3.4 16 17,570,887 - 17,574,389 (+) NCBI RGSC_v3.4 RGSC_v3.4 rn4 Celera 16 17,235,343 - 17,236,847 (+) NCBI Celera Cytogenetic Map 16 p14 NCBI
SFTPA1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 10 79,610,939 - 79,615,455 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 10 79,610,412 - 79,616,115 (+) Ensembl hg38 GRCh38 GRCh37 10 81,370,695 - 81,375,211 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 10 81,040,722 - 81,045,208 (+) NCBI Build 36 Build 36 hg18 NCBI36 Build 34 10 81,360,663 - 81,363,921 NCBI Celera 10 74,655,786 - 74,660,290 (+) NCBI Celera Cytogenetic Map 10 q22.3 NCBI HuRef 10 75,365,719 - 75,370,230 (+) NCBI HuRef CHM1_1 10 81,653,316 - 81,657,819 (+) NCBI CHM1_1 T2T-CHM13v2.0 10 80,480,108 - 80,484,632 (+) NCBI T2T-CHM13v2.0
Sftpa1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 14 40,853,745 - 40,858,330 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 14 40,853,739 - 40,858,409 (+) Ensembl GRCm39 Ensembl GRCm39 GRCm38 14 41,131,788 - 41,136,373 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 14 41,131,782 - 41,136,452 (+) Ensembl mm10 GRCm38 MGSCv37 14 41,945,077 - 41,949,662 (+) NCBI MGSCv37 MGSCv37 mm9 NCBIm37 MGSCv36 14 40,040,501 - 40,045,086 (+) NCBI MGSCv36 mm8 Celera 14 37,291,836 - 37,296,421 (+) NCBI Celera Cytogenetic Map 14 B NCBI cM Map 14 22.36 NCBI
LOC103783265 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 8 92,137,770 - 92,140,202 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 10 92,143,130 - 92,145,527 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 10 76,571,312 - 76,575,820 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 10 80,176,241 - 80,177,151 (-) NCBI PanPan1.1 PanPan1.1 panPan2
LOC610540 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 4 29,430,139 - 29,434,640 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 4 29,554,528 - 29,559,038 (-) NCBI Dog10K_Boxer_Tasha Dog10K_Boxer_Tasha ROS_Cfam_1.0 4 29,732,348 - 29,736,864 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 UMICH_Zoey_3.1 4 29,601,811 - 29,606,320 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 4 29,804,500 - 29,809,005 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 4 30,158,495 - 30,163,007 (-) NCBI UU_Cfam_GSD_1.0 UU_Cfam_GSD_1.0
SFTPA1 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 14 82,091,178 - 82,095,393 (-) Ensembl susScr11 Sscrofa11.1 Sscrofa11.1 14 82,091,178 - 82,095,393 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 14 88,698,851 - 88,702,099 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
.
Predicted Target Of
Count of predictions: 220 Count of miRNA genes: 148 Interacting mature miRNAs: 166 Transcripts: ENSRNOT00000047870 Prediction methods: Microtar, Miranda, Rnahybrid Result types: miRGate_prediction
1549842 Bp248 Blood pressure QTL 248 0.01 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 16 387123 45387123 Rat 2307172 Activ4 Activity QTL 4 3.71 0.00023 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 16 1 33425095 Rat 1354584 Despr6 Despair related QTL 6 3.1 0.0067 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 16 1 39568015 Rat 737819 Hcas4 Hepatocarcinoma susceptibility QTL 4 4.43 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 16 4234212 53708481 Rat 631517 Scl9 Serum cholesterol level QTL 9 3.3 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 16 15748006 25801629 Rat 1354625 Despr7 Despair related QTL 7 3.16 0.016 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 16 4744222 49744222 Rat 61405 Niddm6 Non-insulin dependent diabetes mellitus QTL 6 3.66 0.001 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 16 1 26734272 Rat 631830 Alc7 Alcohol consumption QTL 7 2.9 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 16 1 26734272 Rat 7411664 Foco30 Food consumption QTL 30 11 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 16 4354822 49354822 Rat 1600378 Arunc4 Aerobic running capacity QTL 4 0.03 exercise endurance trait (VT:0002332) longest distance run on treadmill (CMO:0001406) 16 387123 45387123 Rat 70183 BpQTLcluster13 Blood pressure QTL cluster 13 3.654 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 16 4234212 49757901 Rat 737826 Alc11 Alcohol consumption QTL 11 3.2 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 16 4234212 66955197 Rat 1600369 Hcas8 Hepatocarcinoma susceptibility QTL 8 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 16 16278184 27244292 Rat 2303566 Bw90 Body weight QTL 90 2 body mass (VT:0001259) body weight (CMO:0000012) 16 1 39568015 Rat 2312663 Slep9 Serum leptin concentration QTL 9 0.001 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 16 839086 66195506 Rat 2306902 Bp339 Blood pressure QTL 339 0.01 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 16 3386790 49757901 Rat 1300133 Rf24 Renal function QTL 24 3.64 blood creatinine amount (VT:0005328) creatinine clearance (CMO:0000765) 16 3386790 26128267 Rat 2312660 Bw95 Body weight QTL 95 0.05 inguinal fat pad mass (VT:0010424) inguinal fat pad weight to body weight ratio (CMO:0001253) 16 839086 66195506 Rat 2312666 Insul16 Insulin level QTL 16 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 16 839086 66195506 Rat 634355 Rends4 Renal damage susceptibility QTL 4 0.05 kidney blood vessel morphology trait (VT:0000530) organ lesion measurement (CMO:0000677) 16 1 26734272 Rat 61372 Bp40 Blood pressure QTL 40 2.2 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 16 4234333 17730812 Rat 2293343 Glom16 Glomerulus QTL 16 7.4 kidney glomerulus integrity trait (VT:0010546) kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) 16 839086 52786090 Rat 2301406 Kidm39 Kidney mass QTL 39 0.002 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 16 15905802 60905802 Rat 2312669 Stl23 Serum triglyceride level QTL 23 0.01 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 16 839086 66195506 Rat 6903319 Bw114 Body weight QTL 114 2.7 0.0037 body mass (VT:0001259) body weight (CMO:0000012) 16 3301683 48301683 Rat
D16Mgh2
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 16 17,041,660 - 17,041,828 (+) Marker Load Pipeline mRatBN7.2 16 17,007,576 - 17,007,744 (+) MAPPER mRatBN7.2 Rnor_6.0 16 18,715,416 - 18,715,583 NCBI Rnor6.0 Rnor_5.0 16 18,585,028 - 18,585,195 UniSTS Rnor5.0 RGSC_v3.4 16 17,570,281 - 17,570,446 RGD RGSC3.4 RGSC_v3.4 16 17,570,282 - 17,570,449 UniSTS RGSC3.4 RGSC_v3.1 16 17,570,279 - 17,570,444 RGD RH 3.4 Map 16 170.6 UniSTS RH 3.4 Map 16 170.6 RGD RH 2.0 Map 16 142.7 RGD SHRSP x BN Map 16 5.71 RGD FHH x ACI Map 16 12.1799 RGD Cytogenetic Map 16 p14 UniSTS
RH136969
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 16 17,011,434 - 17,011,625 (+) MAPPER mRatBN7.2 Rnor_6.0 16 18,719,153 - 18,719,343 NCBI Rnor6.0 Rnor_5.0 16 18,588,765 - 18,588,955 UniSTS Rnor5.0 RGSC_v3.4 16 17,574,140 - 17,574,330 UniSTS RGSC3.4 Celera 16 17,236,596 - 17,236,786 UniSTS RH 3.4 Map 16 167.1 UniSTS Cytogenetic Map 16 p14 UniSTS
Sftpa1
Rat Assembly Chr Position (strand) Source JBrowse Rnor_6.0 16 18,717,098 - 18,717,980 NCBI Rnor6.0 Rnor_5.0 16 18,586,710 - 18,587,592 UniSTS Rnor5.0 RGSC_v3.4 16 17,571,964 - 17,572,967 UniSTS RGSC3.4 Cytogenetic Map 16 p14 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
9
21
31
73
80
49
50
49
2
161
85
4
18
10
23
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000047870 ⟹ ENSRNOP00000039850
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 Ensembl 16 17,042,255 - 17,045,769 (+) Ensembl mRatBN7.2 Ensembl 16 17,008,180 - 17,011,685 (+) Ensembl Rnor_6.0 Ensembl 16 18,716,019 - 18,719,403 (+) Ensembl
RefSeq Acc Id:
NM_001270645 ⟹ NP_001257574
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 17,042,264 - 17,045,770 (+) NCBI mRatBN7.2 16 17,008,180 - 17,011,686 (+) NCBI Rnor_6.0 16 18,716,019 - 18,719,404 (+) NCBI Rnor_5.0 16 18,585,631 - 18,589,016 (+) NCBI Celera 16 17,235,343 - 17,236,847 (+) NCBI
Sequence:
GGCAGATATCCACACAGCCTGCAGGCTCTGTATGTGGCAGAAGCCACTGGGGATAGTAGCCATGTCACTGTGTTCTTTGGCCTTCACCCTCTTCTTGACTGTTGTCGCTGGTATCAAGTGCAATGTGA CAGACGTTTGTGCTGGAAGCCCTGGGATCCCTGGAGCTCCTGGAAACCATGGTCTGCCTGGCAGAGACGGGAGAGACGGTGTCAAAGGAGACCCTGGACCTCCAGGTCCCATGGGCCCTCCTGGAGGA ATGCCAGGTCTTCCTGGACGCGATGGGCTGCCCGGAGCCCCTGGTGCACCTGGAGAACGTGGAGACAAGGGAGAGCCTGGAGAAAGGGGCCTGCCAGGATTTCCAGCTTACCTGGATGAGGAGCTCCA GACTGAACTCTATGAGATCAAACATCAGATTCTGCAAACAATGGGAGTCCTCAGCTTGCAAGGATCCATGCTGTCAGTGGGGGATAAAGTCTTTTCCACCAATGGGCAGTCAGTCAACTTTGATACCA TTAAAGAGATGTGTACCAGAGCAGGAGGCAACATTGCTGTCCCGAGGACTCCTGAGGAGAACGAGGCCATTGCAAGTATTGCGAAGAAGTACAACAACTATGTCTACTTGGGCATGATTGAAGACCAG ACTCCTGGAGACTTCCACTACCTGGATGGGGCTTCTGTGAACTACACCAACTGGTACCCAGGAGAACCCAGGGGTCAGGGCAAAGAAAAGTGTGTAGAAATGTATACAGATGGGACATGGAATGATAG GGGCTGCCTGCAGTACCGGCTGGCTGTTTGTGAATTTTGATCAAGCAATTAGACGAAAAGATGAACCCTCACACTGCCTCTATCCTGATGATTCATCTGGTCTGTAAAACCCTGCAACTACCTTTCAA GCAAATTTACTTGTGGCCTTCAGAATTAGAAGCATCTTTTGTCACCCCGCTCCCACATAGTTCCCAAACACTTCTCCATATTCATTAGCAATCCTGAGTGTTTCCCTAGAGTCCCATCTGAGCGTTCA TTCAAGGTAGCCATTGTAAACCTTGGCCTTGACCATGAGATGGATAGATACTTCCTTTTTCCTCACTTTATCCAGTCTTCATTTATAAATGGTGGCCATGAAGACCCAGCATGGAAGGACCCTCTAAA CTAAGTGCTGCCCTCTGACCTTTCCACCCTTCTGTAGCTCGGTGTCCCAGGATTTAGAAGTCCAGGTTAAACATAGGGGATTTCTGGGAAAGCCTAGTATGTGGGTGCAGGCCACATTCAGTGCCATC TGTATCCATGGCTTTCAAGGCAAACATTGTCTCTAAGAAGCCAGAGAACCAGGTAGGACCAGGTAGTACTGGGGGAACATAAACTCACTGGTTGGCATGTATGGCTCCCTCCTTGGGTCTGGAGGTGC CATCTTGACCTCTTGAACTAACAGCAGCCACCCTGGGTTTTGAGAGAACGACTTTCCCAGCCCAGACCCCAACTCAAGTAATTTCCTGCTAACAGACACAGCCTCAGTTCACTTTACATCACTGAGGC ATTCATGATACGAACTGCAATCTGTTTTCTCCTCTCGTGAGTTCAATCAGCTATTCCATTAAAGTCAACTGCATTCCAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NM_001270647 ⟹ NP_001257576
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 17,042,264 - 17,045,770 (+) NCBI mRatBN7.2 16 17,008,180 - 17,011,686 (+) NCBI Rnor_6.0 16 18,716,019 - 18,719,404 (+) NCBI Rnor_5.0 16 18,585,631 - 18,589,016 (+) NCBI Celera 16 17,235,343 - 17,236,847 (+) NCBI
Sequence:
GGCAGATATCCACACAGCCTGCAGGCTCTGTATGTGGGGATCTGAAGTCAGAGGCATCCAGTGTGATTTAGATACCAGATGGTGCTGGGGATTTCTGACTGGGAATAGTTTGGGTCTTCTTGGGTCGA CTTGAACCTGCCTGTCGAGTTCTTCTGTGTTCCTGGGTCCTGCAAAGTGCGGCAGGAATGGGGGTCAGAGGAGAGCTATGCTAATGTGACAGGTTGGCTGATGGTCCTTCCCTCCCGCAGCAGAAGCC ACTGGGGATAGTAGCCATGTCACTGTGTTCTTTGGCCTTCACCCTCTTCTTGACTGTTGTCGCTGGTATCAAGTGCAATGTGACAGACGTTTGTGCTGGAAGCCCTGGGATCCCTGGAGCTCCTGGAA ACCATGGTCTGCCTGGCAGAGACGGGAGAGACGGTGTCAAAGGAGACCCTGGACCTCCAGGTCCCATGGGCCCTCCTGGAGGAATGCCAGGTCTTCCTGGACGCGATGGGCTGCCCGGAGCCCCTGGT GCACCTGGAGAACGTGGAGACAAGGGAGAGCCTGGAGAAAGGGGCCTGCCAGGATTTCCAGCTTACCTGGATGAGGAGCTCCAGACTGAACTCTATGAGATCAAACATCAGATTCTGCAAACAATGGG AGTCCTCAGCTTGCAAGGATCCATGCTGTCAGTGGGGGATAAAGTCTTTTCCACCAATGGGCAGTCAGTCAACTTTGATACCATTAAAGAGATGTGTACCAGAGCAGGAGGCAACATTGCTGTCCCGA GGACTCCTGAGGAGAACGAGGCCATTGCAAGTATTGCGAAGAAGTACAACAACTATGTCTACTTGGGCATGATTGAAGACCAGACTCCTGGAGACTTCCACTACCTGGATGGGGCTTCTGTGAACTAC ACCAACTGGTACCCAGGAGAACCCAGGGGTCAGGGCAAAGAAAAGTGTGTAGAAATGTATACAGATGGGACATGGAATGATAGGGGCTGCCTGCAGTACCGGCTGGCTGTTTGTGAATTTTGATCAAG CAATTAGACGAAAAGATGAACCCTCACACTGCCTCTATCCTGATGATTCATCTGGTCTGTAAAACCCTGCAACTACCTTTCAAGCAAATTTACTTGTGGCCTTCAGAATTAGAAGCATCTTTTGTCAC CCCGCTCCCACATAGTTCCCAAACACTTCTCCATATTCATTAGCAATCCTGAGTGTTTCCCTAGAGTCCCATCTGAGCGTTCATTCAAGGTAGCCATTGTAAACCTTGGCCTTGACCATGAGATGGAT AGATACTTCCTTTTTCCTCACTTTATCCAGTCTTCATTTATAAATGGTGGCCATGAAGACCCAGCATGGAAGGACCCTCTAAACTAAGTGCTGCCCTCTGACCTTTCCACCCTTCTGTAGCTCGGTGT CCCAGGATTTAGAAGTCCAGGTTAAACATAGGGGATTTCTGGGAAAGCCTAGTATGTGGGTGCAGGCCACATTCAGTGCCATCTGTATCCATGGCTTTCAAGGCAAACATTGTCTCTAAGAAGCCAGA GAACCAGGTAGGACCAGGTAGTACTGGGGGAACATAAACTCACTGGTTGGCATGTATGGCTCCCTCCTTGGGTCTGGAGGTGCCATCTTGACCTCTTGAACTAACAGCAGCCACCCTGGGTTTTGAGA GAACGACTTTCCCAGCCCAGACCCCAACTCAAGTAATTTCCTGCTAACAGACACAGCCTCAGTTCACTTTACATCACTGAGGCATTCATGATACGAACTGCAATCTGTTTTCTCCTCTCGTGAGTTCA ATCAGCTATTCCATTAAAGTCAACTGCATTCCAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NM_017329 ⟹ NP_059025
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 17,042,264 - 17,045,770 (+) NCBI mRatBN7.2 16 17,008,180 - 17,011,686 (+) NCBI Rnor_6.0 16 18,716,019 - 18,719,404 (+) NCBI Rnor_5.0 16 18,585,631 - 18,589,016 (+) NCBI RGSC_v3.4 16 17,570,887 - 17,574,389 (+) RGD Celera 16 17,235,343 - 17,236,847 (+) NCBI
Sequence:
GGCAGATATCCACACAGCCTGCAGGCTCTGTATGTGGAAGCCACTGGGGATAGTAGCCATGTCA CTGTGTTCTTTGGCCTTCACCCTCTTCTTGACTGTTGTCGCTGGTATCAAGTGCAATGTGACAGACGTTTGTGCTGGAAGCCCTGGGATCCCTGGAGCTCCTGGAAACCATGGTCTGCCTGGCAGAGA CGGGAGAGACGGTGTCAAAGGAGACCCTGGACCTCCAGGTCCCATGGGCCCTCCTGGAGGAATGCCAGGTCTTCCTGGACGCGATGGGCTGCCCGGAGCCCCTGGTGCACCTGGAGAACGTGGAGACA AGGGAGAGCCTGGAGAAAGGGGCCTGCCAGGATTTCCAGCTTACCTGGATGAGGAGCTCCAGACTGAACTCTATGAGATCAAACATCAGATTCTGCAAACAATGGGAGTCCTCAGCTTGCAAGGATCC ATGCTGTCAGTGGGGGATAAAGTCTTTTCCACCAATGGGCAGTCAGTCAACTTTGATACCATTAAAGAGATGTGTACCAGAGCAGGAGGCAACATTGCTGTCCCGAGGACTCCTGAGGAGAACGAGGC CATTGCAAGTATTGCGAAGAAGTACAACAACTATGTCTACTTGGGCATGATTGAAGACCAGACTCCTGGAGACTTCCACTACCTGGATGGGGCTTCTGTGAACTACACCAACTGGTACCCAGGAGAAC CCAGGGGTCAGGGCAAAGAAAAGTGTGTAGAAATGTATACAGATGGGACATGGAATGATAGGGGCTGCCTGCAGTACCGGCTGGCTGTTTGTGAATTTTGATCAAGCAATTAGACGAAAAGATGAACC CTCACACTGCCTCTATCCTGATGATTCATCTGGTCTGTAAAACCCTGCAACTACCTTTCAAGCAAATTTACTTGTGGCCTTCAGAATTAGAAGCATCTTTTGTCACCCCGCTCCCACATAGTTCCCAA ACACTTCTCCATATTCATTAGCAATCCTGAGTGTTTCCCTAGAGTCCCATCTGAGCGTTCATTCAAGGTAGCCATTGTAAACCTTGGCCTTGACCATGAGATGGATAGATACTTCCTTTTTCCTCACT TTATCCAGTCTTCATTTATAAATGGTGGCCATGAAGACCCAGCATGGAAGGACCCTCTAAACTAAGTGCTGCCCTCTGACCTTTCCACCCTTCTGTAGCTCGGTGTCCCAGGATTTAGAAGTCCAGGT TAAACATAGGGGATTTCTGGGAAAGCCTAGTATGTGGGTGCAGGCCACATTCAGTGCCATCTGTATCCATGGCTTTCAAGGCAAACATTGTCTCTAAGAAGCCAGAGAACCAGGTAGGACCAGGTAGT ACTGGGGGAACATAAACTCACTGGTTGGCATGTATGGCTCCCTCCTTGGGTCTGGAGGTGCCATCTTGACCTCTTGAACTAACAGCAGCCACCCTGGGTTTTGAGAGAACGACTTTCCCAGCCCAGAC CCCAACTCAAGTAATTTCCTGCTAACAGACACAGCCTCAGTTCACTTTACATCACTGAGGCATTCATGATACGAACTGCAATCTGTTTTCTCCTCTCGTGAGTTCAATCAGCTATTCCATTAAAGTCA ACTGCATTCCAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_039094199 ⟹ XP_038950127
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 16 17,042,377 - 17,045,770 (+) NCBI mRatBN7.2 16 17,008,293 - 17,011,686 (+) NCBI
RefSeq Acc Id:
NP_059025 ⟸ NM_017329
- Peptide Label:
isoform 2 precursor
- UniProtKB:
P08427 (UniProtKB/Swiss-Prot)
- Sequence:
MWKPLGIVAMSLCSLAFTLFLTVVAGIKCNVTDVCAGSPGIPGAPGNHGLPGRDGRDGVKGDPGPPGPMGPPGGMPGLPGRDGLPGAPGAPGERGDKGEPGERGLPGFPAYLDEELQTELYEIKHQIL QTMGVLSLQGSMLSVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMIEDQTPGDFHYLDGASVNYTNWYPGEPRGQGKEKCVEMYTDGTWNDRGCLQYRLAVCE F
hide sequence
RefSeq Acc Id:
NP_001257574 ⟸ NM_001270645
- Peptide Label:
isoform 1 precursor
- UniProtKB:
P08427 (UniProtKB/Swiss-Prot)
- Sequence:
MWQKPLGIVAMSLCSLAFTLFLTVVAGIKCNVTDVCAGSPGIPGAPGNHGLPGRDGRDGVKGDP GPPGPMGPPGGMPGLPGRDGLPGAPGAPGERGDKGEPGERGLPGFPAYLDEELQTELYEIKHQILQTMGVLSLQGSMLSVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYN NYVYLGMIEDQTPGDFHYLDGASVNYTNWYPGEPRGQGKEKCVEMYTDGTWNDRGCLQYRLAVCEF
hide sequence
RefSeq Acc Id:
NP_001257576 ⟸ NM_001270647
- Peptide Label:
isoform 3 precursor
- UniProtKB:
P08427 (UniProtKB/Swiss-Prot)
- Sequence:
MSLCSLAFTLFLTVVAGIKCNVTDVCAGSPGIPGAPGNHGLPGRDGRDGVKGDPGPPGPMGPPGGMPGLPGRDGLPGAPGAPGERGDKGEPGERGLPGFPAYLDEELQTELYEIKHQILQTMGVLSLQ GSMLSVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMIEDQTPGDFHYLDGASVNYTNWYPGEPRGQGKEKCVEMYTDGTWNDRGCLQYRLAVCEF
hide sequence
Ensembl Acc Id:
ENSRNOP00000039850 ⟸ ENSRNOT00000047870
RefSeq Acc Id:
XP_038950127 ⟸ XM_039094199
- Peptide Label:
isoform X1
- UniProtKB:
P08427 (UniProtKB/Swiss-Prot)
RGD ID: 13699975
Promoter ID: EPDNEW_R10497
Type: multiple initiation site
Name: Sftpa1_1
Description: surfactant protein A1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 16 18,716,010 - 18,716,070 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2015-05-18
Sftpa1
surfactant protein A1
LOC102557073
pulmonary surfactant-associated protein A-like
Data merged from RGD:7634712
737654
APPROVED
2013-12-18
LOC102557073
pulmonary surfactant-associated protein A-like
Symbol and Name status set to provisional
70820
PROVISIONAL
2013-03-29
Sftpa1
surfactant protein A1
LOC100364823
pulmonary surfactant-associated protein A-like
Data merged from RGD:2320242
737654
PROVISIONAL
2010-05-05
LOC100364823
pulmonary surfactant-associated protein A-like
Symbol and Name status set to provisional
70820
PROVISIONAL
2009-02-26
Sftpa1
surfactant protein A1
Sftpa1
surfactant, pulmonary-associated protein A1
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2003-04-09
Sftpa1
surfactant, pulmonary-associated protein A1
Surfactant-associated protein 1 (pulmonary surfactant protein, SP-A)
Name updated
629478
APPROVED